Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients.

Background/aim: Pyoderma gangrenosum (PG) is a rare, neutrophilic dermatosis often associated with an underlying disease, and clinical data or larger studies are rare.Methods: In this retrospective study, disease characteristics, clinical manifestations, and treatment response were evaluated in a Sw...

Descripción completa

Detalles Bibliográficos
Publicado en:Dermatology (10188665) Vol. 233; no. 4; pp. 268 - 277
Autores principales: Kolios, Antonios G.A., Gübeli, Alissa, Meier, Barbara, Maul, Julia-Tatjana, Kündig, Thomas, Nilsson, Jakob, Hafner, Jürg, Guenova, Emmanuella, Kerl, Katrin, Anliker, Mark, Kempf, Werner, Navarini, Alexander A., French, Lars E., Cozzio, Antonio
Formato: research tables/charts Journal Article
Publicado: Karger AG Jan2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=127281524&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 127281524
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10188665
        NIG
      jtl: Dermatology (10188665)
      issn: 10188665
      maglogo: N
    pubinfo:
      dt: Jan2018
      vid: 233
      iid: 4
      pid: 2485
      pub: Karger AG
    artinfo:
      ui:
        127281524
        127281524
        NLM29130957
        127281524
        10.1159/000481432
        NLM29130957
        127281524
      ppf: 268
      ppct: 9
      formats:
      tig:
        atl: Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients.
      aug:
        au:
          Kolios, Antonios G.A.
          Gübeli, Alissa
          Meier, Barbara
          Maul, Julia-Tatjana
          Kündig, Thomas
          Nilsson, Jakob
          Hafner, Jürg
          Guenova, Emmanuella
          Kerl, Katrin
          Anliker, Mark
          Kempf, Werner
          Navarini, Alexander A.
          French, Lars E.
          Cozzio, Antonio
          Gübeli, Alissa
          Kündig, Thomas
          Hafner, Jürg
      sug:
        subj:
          Dermatologic Agents Administration and Dosage
          Pyoderma Gangrenosum Epidemiology
          Skin Pathology
          Adolescence
          Prospective Studies
          Male
          Retrospective Design
          Administration, Transcutaneous
          Female
          Adult
          Switzerland
          Pyoderma Gangrenosum Diagnosis
          Incidence
          Young Adult
          Severity of Illness Indices
          Aged, 80 and Over
          Pyoderma Gangrenosum Drug Therapy
          Aged
          Biopsy
          Middle Age
          Human
          Adolescent: 13-18 years
          Adult: 19-44 years
          Aged, 80 & over
          Aged: 65+ years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Background/aim: Pyoderma gangrenosum (PG) is a rare, neutrophilic dermatosis often associated with an underlying disease, and clinical data or larger studies are rare.Methods: In this retrospective study, disease characteristics, clinical manifestations, and treatment response were evaluated in a Swiss cohort of PG patients.Results: In participating centers, 34 cases (21 females) of PG were analyzed based on clinical and histological presentation between 2002 and 2012. The mean age at diagnosis was 61.2 years; 50% of the patients experienced only 1 episode of PG. In 13 cases (out of 20), recurrences occurred during PG therapy; 64.1% showed only 1 lesion simultaneously. The predominant localization was the lower limb (67%). The lesions were disseminated in 26.6%. At the time of diagnosis or recurrence, the mean diameter was 37.6 mm and the mean ulcer size was 10.3 cm2. C-reactive protein (CRP) was elevated in 73.2%; leukocytosis was present in 58.9% and neutrophilia in 50.9%. At least 1 associated comorbidity was present in 85% (the most prominent being cardiovascular disease). The most often used systemic treatments were steroids (68.3%), cyclosporine A (31.7%), dapsone (31.7%), and infliximab (13.3%), and the most often used topicals were tacrolimus 0.1% (48.3%) and corticosteroids (35%). PG healed completely at discharge in 50.8%. The average time to diagnosis was 8 months, and the mean duration to healing was 7.1 months.Conclusion: PG is a difficult-to-diagnose skin disease. Here, markers for inflammation such as CRP, leukocytosis, and neutrophilia were elevated in 50-73% of the PG patients.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N